The Scientific Visualization and Image Analysis (SVIA) Core plays an important role in the UCCRC;its services help to promote collaborations that allow imaging to be used by a number of other programs in the UCRRC. The Core provides three essential services: a high performance computer cluster, a large data storage resource, and software to facilitate the development of databases. In 2007, the computation capabilities of the Core will be upgraded using funds from a recently awarded Shared Instrumentation Grant from the NIH. The new system will have 128 CPUs and 14 TBytes of storage. The Core facilitates the development of databases of patient data by providing a means to collect deidentified patient records, including image data. Since the image is collected in such a way that patient identifiers are removed, researchers do not need to obtain patient consent, and their research is HIPAA compliant. Without this service, collecting patient images would be extremely difficult and timeconsuming. Nearly 4000 patient cases (679 GBytes) were collected in this way. All of these users are conducting research on computer-aided diagnosis, but the Core also supports research on image reconstruction, MR imaging and spectroscopy, electron paramagnetic imaging, and receiver-operating characteristic (ROC) analysis. While most users of the SVIA Core are from the Advanced Imaging Program, the use of the Core facilitates collaborations with members of other Programs, such as the Cancer Risk and Prevention Program. The SVIA Core's future plans include supporting the expansion of the Advanced Imaging Program to promote collaboration between experts in medical imaging and members in other programs. One way this will be done is to create a list of software developed by members of the Advanced Imaging Program that is available to UCCRC members. The goal is to have non-imaging experts team up with members of the Advanced Imaging Program to apply or modify existing software to solve or help solve problems in the basic biological sciences or in clinical medicine.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-35
Application #
8105364
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
35
Fiscal Year
2010
Total Cost
$103,596
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Hope, C Matthew; Webber, Jemma L; Tokamov, Sherzod A et al. (2018) Tuned polymerization of the transcription factor Yan limits off-DNA sequestration to confer context-specific repression. Elife 7:
Wu, Chengyue; Pineda, Federico; Hormuth 2nd, David A et al. (2018) Quantitative analysis of vascular properties derived from ultrafast DCE-MRI to discriminate malignant and benign breast tumors. Magn Reson Med :
Wong, Gabrielle S; Zhou, Jin; Liu, Jie Bin et al. (2018) Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. Nat Med 24:968-977
Ni, Kaiyuan; Lan, Guangxu; Chan, Christina et al. (2018) Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy. Nat Commun 9:2351
Meisel, Marlies; Hinterleitner, Reinhard; Pacis, Alain et al. (2018) Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 557:580-584
Webber, Jemma L; Zhang, Jie; Massey, Alex et al. (2018) Collaborative repressive action of the antagonistic ETS transcription factors Pointed and Yan fine-tunes gene expression to confer robustness in Drosophila. Development 145:
Wei, Jiangbo; Liu, Fange; Lu, Zhike et al. (2018) Differential m6A, m6Am, and m1A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm. Mol Cell 71:973-985.e5
Boisclair Lachance, Jean-François; Webber, Jemma L; Hong, Lu et al. (2018) Cooperative recruitment of Yan via a high-affinity ETS supersite organizes repression to confer specificity and robustness to cardiac cell fate specification. Genes Dev 32:389-401
Szmulewitz, Russell Z; Peer, Cody J; Ibraheem, Abiola et al. (2018) Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer. J Clin Oncol 36:1389-1395
Maron, Steven B; Alpert, Lindsay; Kwak, Heewon A et al. (2018) Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR-Amplified Gastroesophageal Adenocarcinoma. Cancer Discov 8:696-713

Showing the most recent 10 out of 668 publications